The optimal management of headaches in children and adolescents.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 1, p. 53, doi. 10.1177/1756285615616586
- By:
- Publication type:
- Article
Works matching IS 17562856 AND DT 2016 AND VI 9 AND IP 1
Results: 6
1
2
Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 1, p. 31, doi. 10.1177/1756285615615257
- By:
- Publication type:
- Article
3
Progressive encephalomyelitis with rigidity and myoclonus (PERM): brucellosis as a possible triggering factor and long-term follow-up therapy with rituximab.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 1, p. 69, doi. 10.1177/1756285615614812
- By:
- Publication type:
- Article
4
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 1, p. 9, doi. 10.1177/1756285615612659
- By:
- Publication type:
- Article
5
A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain–Barré syndrome in Upper Egypt.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 1, p. 3, doi. 10.1177/1756285615610471
- By:
- Publication type:
- Article
6
The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2016, v. 9, n. 1, p. 44, doi. 10.1177/1756285615601933
- By:
- Publication type:
- Article